← Back
$AUPH All transactions

Aurinia Pharmaceuticals Inc.

F

$ Value

$579K

Shares

40,761

Price

$14

Filed

Mar 3

Insider

Name

Donley Matthew Maxwell

Title

Chief Operating Officer

CIK

0001636642

Roles

Officer

Transaction Details

Transaction Date

2026-03-02

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

680,299

Footnotes

Each performance right represents a contingent right to receive one common share of the Issuer. The performance rights vest in four tranches upon the Issuer's common shares achieving four progressively higher target prices, with respective one year retention periods per tranche achievement. | Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units. | One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter.

Filing Info

Accession No.

0001600620-26-000022

Form Type

4

Issuer CIK

0001600620

Donley Matthew Maxwell's History

Date Ticker Type Value
2026-03-02 AUPH F $579K
2026-02-27 AUPH A $0
2026-02-27 AUPH A $0
2026-02-20 AUPH F $474K
2026-01-02 AUPH A $0
2026-01-02 AUPH F $682K

Other Insiders at AUPH (90d)

Insider Bought Sold Last
TANG KEVIN $12.7M 2026-03-03
Greenleaf Peter
Chief Executive Officer
2026-03-02
Donley Matthew Maxwell
Chief Operating Officer
2026-02-27
Miller Joseph M
Chief Financial Officer
2026-03-02
Robertson Stephen P.
EVP, General Counsel
2026-03-02
Keenan Greg
SVP, Chief Medical Officer
2026-03-06